Modeling health benefits and harms of public policy responses to the US opioid epidemic
AL Pitt, K Humphreys… - American journal of …, 2018 - ajph.aphapublications.org
Objectives. To estimate health outcomes of policies to mitigate the opioid epidemic.
Methods. We used dynamic compartmental modeling of US adults, in various pain, opioid …
Methods. We used dynamic compartmental modeling of US adults, in various pain, opioid …
[PDF][PDF] Abuse-deterrent opioid formulations
RS Litman, OH Pagán, TJ Cicero - Anesthesiology, 2018 - academia.edu
Abuse-deterrent opioid formulations have been suggested as one way to decrease the
abuse, addiction, and overdose of orally prescribed opioids. Ten oral opioid formulations …
abuse, addiction, and overdose of orally prescribed opioids. Ten oral opioid formulations …
Abuse-deterrent opioids: an update on current approaches and considerations
JV Pergolizzi Jr, RB Raffa, R Taylor Jr… - … medical research and …, 2018 - Taylor & Francis
Objective: Abuse and misuse of prescription opioids is a significant public health concern.
This review examines the strategies used to confer abuse-deterrent properties on opioid …
This review examines the strategies used to confer abuse-deterrent properties on opioid …
Abuse deterrent immediate release egg-shaped tablet (Egglets) using 3D printing technology: quality by design to optimize drug release and extraction
Opioid abuse is a growing problem and has become a national health crisis over the past
decade in the USA. Oral ingestion, snorting, and injection are the most commonly employed …
decade in the USA. Oral ingestion, snorting, and injection are the most commonly employed …
Abuse-deterrent formulations and opioid-related harms in North Carolina, 2010-2018
Abuse-deterrent formulations of opioid analgesics (ADFs) were introduced to reduce opioid-
related harms among pain patients, but postmarketing study results have been mixed …
related harms among pain patients, but postmarketing study results have been mixed …
[HTML][HTML] Medical outcomes associated with prescription opioid abuse via oral and non-oral routes of administration
JL Green, BB Bartelson, MC Le Lait, CL Roland… - Drug and alcohol …, 2017 - Elsevier
Background Prescription opioid abuse and misuse is a serious and growing public health
issue. While the most common form of abuse is swallowing intact tablets/capsules, some …
issue. While the most common form of abuse is swallowing intact tablets/capsules, some …
[HTML][HTML] Assessment of tapentadol API abuse liability with the researched abuse, diversion and addiction-related surveillance system
SK Vosburg, SG Severtson, RC Dart, TJ Cicero… - The Journal of …, 2018 - Elsevier
Tapentadol, a Schedule II opioid with a combination of µ-opioid activity and norepinephrine
reuptake inhibition, is used for the management of moderate to severe acute and chronic …
reuptake inhibition, is used for the management of moderate to severe acute and chronic …
Law enforcement‐derived data on gabapentin diversion and misuse, 2002‐2015: diversion rates and qualitative research findings
Purpose Recent limited epidemiologic and case reports suggest that gabapentin is being
misused, especially among prescription opioid misusers. However, no apparent studies …
misused, especially among prescription opioid misusers. However, no apparent studies …
Abuse and diversion of immediate release opioid analgesics as compared to extended release formulations in the United States
Background Therapeutic use and abuse of prescription opioids in the United States
increased substantially between 1990 and 2010. The Centers for Disease Control estimated …
increased substantially between 1990 and 2010. The Centers for Disease Control estimated …
Non-medical use of prescription stimulants among college students: non-oral routes of administration, risk factors, motivations, and pathways
SF Butler, SV Faraone, AL Rostain, JH Newcorn… - Frontiers in …, 2021 - frontiersin.org
Introduction: Non-medical use (NMU) of prescription stimulant medications is a continuing
public health concern. Stimulant medications prescribed for attention-deficit/hyperactivity …
public health concern. Stimulant medications prescribed for attention-deficit/hyperactivity …